Immunome Inc.(IMNM)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IMNM Immunome Inc.

休市中 09-18 16:00:00 EDT

23.97

+0.04

+0.17%

盘后24.16

+0.19+0.81%

19:30 EDT

最高24.24	最低23.36	成交量396.29万
今开24.01	昨收23.93	日振幅3.70%
总市值27.22亿	流通市值25.91亿	总股本1.14亿
成交额9,481万	换手率3.67%	流通股本1.08亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"IMNM","market":"US","secType":"STK","nameCN":"Immunome Inc.","latestPrice":23.97,"timestamp":1789761600000,"preClose":23.93,"halted":0,"volume":3962926,"hourTrading":{"tag":"盘后","latestPrice":24.1631,"preClose":23.97,"latestTime":"19:30 EDT","volume":172141,"amount":4126430.556,"timestamp":1789774206526,"change":0.1931,"changeRate":0.008056,"amplitude":0.00839},"delay":0,"changeRate":0.0016715419974926513,"floatShares":108105887,"shares":113577629,"eps":-2.485132,"marketStatus":"休市中","change":0.04,"latestTime":"09-18 16:00:00 EDT","open":24.01,"high":24.24,"low":23.355,"amount":94812584.47984399,"amplitude":0.036983,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.485132,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":7,"adr":0,"listingDate":1601611200000,"exchange":"NASDAQ","adjPreClose":23.93,"preHourTrading":{"tag":"盘前","latestPrice":24.04,"preClose":23.93,"latestTime":"09:29 EDT","volume":1711,"amount":40974.22383,"timestamp":1789738199999,"change":0.11,"changeRate":0.004597,"amplitude":0.039699},"postHourTrading":{"tag":"盘后","latestPrice":24.1631,"preClose":23.97,"latestTime":"19:30 EDT","volume":172141,"amount":4126430.556,"timestamp":1789774206526,"change":0.1931,"changeRate":0.008056,"amplitude":0.00839},"volumeRatio":3.979797954972735,"impliedVol":0.58,"impliedVolPercentile":0.3147},"requestUrl":"/m/hq/s/IMNM/tweets","defaultTab":"tweets","newsList":[{"id":"1102121729","title":"Immunome宣布首例患者入组，启动评估FAP靶向放射性配体疗法IM-3050治疗FAP表达晚期实体瘤的I期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1102121729","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1102121729?lang=zh_cn&edition=full","pubTime":"2026-07-20 19:31","pubTimestamp":1784547073,"startTime":"0","endTime":"0","summary":"Immunome公司宣布，其针对成纤维细胞活化蛋白（FAP）表达晚期实体瘤的靶向放射性配体疗法IM-3050，已在I期临床试验中完成首例患者给药。该试验旨在评估IM-3050的安全性、耐受性及初步疗效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMNM","BK4139","BK4563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151146631","title":"免疫组公司宣布美国FDA受理Varegacestat用于治疗成人硬纤维瘤的新药申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1151146631","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1151146631?lang=zh_cn&edition=full","pubTime":"2026-07-08 19:32","pubTimestamp":1783510371,"startTime":"0","endTime":"0","summary":"免疫组公司宣布，其用于治疗成人硬纤维瘤的新药Varegacestat，其新药申请已获得美国食品药品监督管理局的受理。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4563","IMNM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130286221","title":"Immunome宣布首例晚期实体瘤患者接受潜在首创新药IM-1617 ADC的1期临床试验给药","url":"https://stock-news.laohu8.com/highlight/detail?id=1130286221","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1130286221?lang=zh_cn&edition=full","pubTime":"2026-06-11 19:31","pubTimestamp":1781177475,"startTime":"0","endTime":"0","summary":"Immunome Inc. 宣布，其在研抗体偶联药物IM-1617的1期临床试验已完成首例患者给药。该药物有望成为同类首创疗法，用于治疗晚期实体瘤患者。这项重要进展标志着公司向临床开发迈出了关键一步，也展现了其在肿瘤治疗领域的创新潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMNM","BK4563","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151042498","title":"Immunome公司Varegacestat疗法在主要及所有关键次要疗效终点上均显示出统计学显著改善","url":"https://stock-news.laohu8.com/highlight/detail?id=1151042498","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1151042498?lang=zh_cn&edition=full","pubTime":"2026-05-30 20:13","pubTimestamp":1780143195,"startTime":"0","endTime":"0","summary":"Immunome公司宣布，其药物Varegacestat在临床试验中取得了积极成果。数据显示，该疗法不仅在主要疗效终点上实现了统计学意义的显著改善，而且在所有预先设定的关键次要疗效终点上也同样观察到了具有统计学意义的积极变化。这一结果标志着该候选药物在相关治疗领域取得了重要进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","BK4139","IMNM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189553126","title":"Immunome向美国FDA提交Varegacestat新药申请 用于成人硬纤维瘤治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1189553126","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1189553126?lang=zh_cn&edition=full","pubTime":"2026-04-29 19:31","pubTimestamp":1777462274,"startTime":"0","endTime":"0","summary":"Immunome Inc. (IMNM) 宣布已正式向美国食品药品监督管理局提交Varegacestat的新药申请，该药物旨在治疗成人硬纤维瘤患者。此次申报标志着公司在肿瘤治疗领域取得重要进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IMNM","BK4563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518746355","title":"Immunome(IMNM.US)获LifeSci Capital首次覆盖，给予优于大市评级, 目标价20.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2518746355","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518746355?lang=zh_cn&edition=full","pubTime":"2025-03-11 20:41","pubTimestamp":1741696887,"startTime":"0","endTime":"0","summary":"Immunome(IMNM.US)获LifeSci Capital首次覆盖，给予优于大市评级, 目标价20.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/11204148668014.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["IMNM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512819160","title":"Immunome, Inc.盘中异动 股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512819160","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512819160?lang=zh_cn&edition=full","pubTime":"2025-02-19 03:58","pubTimestamp":1739908693,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日03时58分，Immunome, Inc.股票出现波动，股价大幅下挫5.00%。截至发稿，该股报9.88美元/股，成交量42.7731万股，换手率0.51%，振幅7.50%。Immunome, Inc.股票所在的生物技术行业中，整体涨幅为0.98%。其相关个股中，Aditxt, Inc.、Allogene Therapeutics, Inc.、Pulmatrix, Inc.涨幅较大，Aditxt, Inc.、Moleculin Biotech, Inc.、Solid Biosciences Inc.较为活跃，换手率分别为882.22%、212.96%、171.17%，振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Abvc Biopharma, Inc.、Allogene Therapeutics, Inc.，振幅分别为148.75%、92.00%、79.17%。Immunome, Inc.公司简介：Immunome Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219035814abd3f209&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219035814abd3f209&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMNM","BK4139","BK4563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510385380","title":"Immunome, Inc.盘中异动 早盘快速下跌5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510385380","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510385380?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:36","pubTimestamp":1739284590,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时36分，Immunome, Inc.股票出现异动，股价大幅下跌5.44%。截至发稿，该股报10.61美元/股，成交量5.6414万股，换手率0.07%，振幅4.28%。Immunome, Inc.股票所在的生物技术行业中，整体跌幅为0.93%。其相关个股中，Dominari Holdings Inc.、Lipella Pharmaceuticals Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为2099.11%、550.07%、194.48%，振幅较大的相关个股有In8Bio, Inc.、Dominari Holdings Inc.、Ocean Biomedical, Inc.，振幅分别为28.77%、25.49%、22.23%。Immunome, Inc.公司简介：Immunome Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223631961f4890&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223631961f4890&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMNM","BK4563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510864332","title":"Immunome, Inc.盘中异动 股价大涨5.24%报11.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510864332","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510864332?lang=zh_cn&edition=full","pubTime":"2025-02-10 22:53","pubTimestamp":1739199198,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日22时53分，Immunome, Inc.股票出现波动，股价大幅拉升5.24%。截至发稿，该股报11.44美元/股，成交量24.9196万股，换手率0.29%，振幅5.24%。Immunome, Inc.股票所在的生物技术行业中，整体涨幅为0.24%。其相关个股中，Biodexa Pharmaceuticals Plc、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Biodexa Pharmaceuticals Plc、Nls Pharmaceutics Ltd.、Ocean Biomedical, Inc.较为活跃，换手率分别为2198.67%、1390.08%、796.51%，振幅较大的相关个股有Biodexa Pharmaceuticals Plc、Ocean Biomedical, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为59.71%、48.38%、39.13%。Immunome, Inc.公司简介：Immunome Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210225318961e04d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210225318961e04d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","BK4139","IMNM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509217727","title":"Immunome, Inc.盘中异动 股价大跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509217727","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509217727?lang=zh_cn&edition=full","pubTime":"2025-02-08 02:26","pubTimestamp":1738952815,"startTime":"0","endTime":"0","summary":"北京时间2025年02月08日02时26分，Immunome, Inc.股票出现波动，股价大幅跳水5.07%。截至发稿，该股报10.85美元/股，成交量40.5262万股，换手率0.48%，振幅6.21%。Immunome, Inc.股票所在的生物技术行业中，整体跌幅为0.56%。其相关个股中，Conduit Pharmaceuticals Inc.、Sionna Therapeutics, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Conduit Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.、Lipella Pharmaceuticals Inc.较为活跃，换手率分别为7710.41%、175.53%、124.43%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Conduit Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.，振幅分别为130.43%、93.55%、54.97%。Immunome, Inc.公司简介：Immunome Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208022655abc65c85&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208022655abc65c85&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","BK4139","IMNM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509704238","title":"Immunome, Inc.盘中异动 大幅上涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509704238","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509704238?lang=zh_cn&edition=full","pubTime":"2025-02-05 23:44","pubTimestamp":1738770248,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日23时44分，Immunome, Inc.股票出现波动，股价急速拉升5.05%。截至发稿，该股报11.64美元/股，成交量18.6467万股，换手率0.22%，振幅4.60%。Immunome, Inc.股票所在的生物技术行业中，整体涨幅为1.45%。其相关个股中，Transcode Therapeutics, Inc.、Oragenics Inc.、Pasithea Therapeutics Corp.涨幅较大，Pasithea Therapeutics Corp.、Oragenics Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为4054.20%、1197.54%、978.89%，振幅较大的相关个股有Transcode Therapeutics, Inc.、Oragenics Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028，振幅分别为86.20%、59.80%、54.05%。Immunome, Inc.公司简介：Immunome Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205234408abc38da4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205234408abc38da4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","IMNM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508345078","title":"Immunome, Inc.盘中异动 早盘股价大涨7.66%报11.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508345078","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508345078?lang=zh_cn&edition=full","pubTime":"2025-02-04 22:32","pubTimestamp":1738679540,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日22时32分，Immunome, Inc.股票出现异动，股价大幅上涨7.66%。截至发稿，该股报11.11美元/股，成交量27.2221万股，换手率0.32%，振幅2.62%。Immunome, Inc.股票所在的生物技术行业中，整体跌幅为0.42%。其相关个股中，Azitra Inc、Evaxion Biotech As、Invivyd, Inc.涨幅较大，Azitra Inc、Evaxion Biotech As、Enveric Biosciences, Inc.较为活跃，换手率分别为892.76%、686.40%、186.00%，振幅较大的相关个股有Azitra Inc、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Omega Therapeutics, Inc.，振幅分别为29.44%、19.74%、18.97%。Immunome, Inc.公司简介：Immunome Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204223220abc22842&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204223220abc22842&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMNM","BK4563","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508149142","title":"Immunome, Inc.盘中异动 快速下挫6.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508149142","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508149142?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:38","pubTimestamp":1738593495,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时38分，Immunome, Inc.股票出现波动，股价急速下跌6.07%。截至发稿，该股报10.36美元/股，成交量3.3495万股，换手率0.04%，振幅3.81%。Immunome, Inc.股票所在的生物技术行业中，整体跌幅为0.39%。其相关个股中，Hcw Biologics Inc.、Gh Research Plc、Invivyd, Inc.涨幅较大，Hcw Biologics Inc.、Cyclerion Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为371.40%、154.88%、56.31%，振幅较大的相关个股有Hcw Biologics Inc.、180 Life Sciences Corp C/Wts 07/11/2025、Invivyd, Inc.，振幅分别为82.17%、33.33%、27.90%。Immunome, Inc.公司简介：Immunome Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502032238159616fcda&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502032238159616fcda&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMNM","BK4139","BK4563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507613899","title":"Immunome, Inc.盘中异动 大幅拉升5.52%报11.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507613899","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507613899?lang=zh_cn&edition=full","pubTime":"2025-01-31 23:19","pubTimestamp":1738336753,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日23时19分，Immunome, Inc.股票出现波动，股价急速上涨5.52%。截至发稿，该股报11.09美元/股，成交量25.4298万股，换手率0.41%，振幅6.01%。Immunome, Inc.股票所在的生物技术行业中，整体涨幅为1.30%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Cyclerion Therapeutics, Inc.、Nls Pharmaceutics Ltd.涨幅较大，Nls Pharmaceutics Ltd.、Cyclerion Therapeutics, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为1775.27%、1636.51%、122.90%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Cyclerion Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为63.20%、56.30%、46.27%。Immunome, Inc.公司简介：Immunome Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131231914a2354b81&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131231914a2354b81&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","BK4139","IMNM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507213096","title":"Immunome, Inc.盘中异动 急速拉升5.03%报9.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507213096","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507213096?lang=zh_cn&edition=full","pubTime":"2025-01-30 22:42","pubTimestamp":1738248175,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日22时42分，Immunome, Inc.股票出现波动，股价快速拉升5.03%。截至发稿，该股报9.82美元/股，成交量81.5031万股，换手率1.31%，振幅6.63%。Immunome, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。其相关个股中，Tectonic Therapeutic, Inc.、Alterity Therapeutics Limited、Kazia Therapeutics Limited涨幅较大，Kazia Therapeutics Limited、Alterity Therapeutics Limited、Silexion Therapeutics Corp较为活跃，换手率分别为1039.95%、143.10%、122.07%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Kazia Therapeutics Limited、Alterity Therapeutics Limited，振幅分别为56.41%、41.30%、29.55%。Immunome, Inc.公司简介：Immunome Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025013022425696143ee4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025013022425696143ee4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMNM","BK4139","BK4563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507543080","title":"Immunome, Inc.盘中异动 急速跳水5.06%报9.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507543080","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507543080?lang=zh_cn&edition=full","pubTime":"2025-01-29 00:42","pubTimestamp":1738082537,"startTime":"0","endTime":"0","summary":"北京时间2025年01月29日00时42分，Immunome, Inc.股票出现异动，股价急速下挫5.06%。截至发稿，该股报9.20美元/股，成交量13.6771万股，换手率0.22%，振幅4.54%。Immunome, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。其相关个股中，Silexion Therapeutics Corp、Transcode Therapeutics, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 涨幅较大，Silexion Therapeutics Corp、Hepion Pharmaceuticals, Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为4451.74%、3349.91%、2570.91%，振幅较大的相关个股有Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Transcode Therapeutics, Inc.，振幅分别为236.17%、122.16%、102.05%。Immunome, Inc.公司简介：Immunome Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129004217abbb80b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129004217abbb80b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","BK4139","IMNM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505204975","title":"Immunome, Inc.盘中异动 急速上涨5.11%报10.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505204975","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505204975?lang=zh_cn&edition=full","pubTime":"2025-01-22 01:41","pubTimestamp":1737481277,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日01时41分，Immunome, Inc.股票出现异动，股价急速拉升5.11%。截至发稿，该股报10.50美元/股，成交量15.1032万股，换手率0.24%，振幅6.36%。Immunome, Inc.股票所在的生物技术行业中，整体涨幅为2.02%。其相关个股中，Camp4 Therapeutics Corporation、Dogwood Therapeutics, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com涨幅较大，Dogwood Therapeutics, Inc.、Channel Therapeutics Corporation、Dermata Therapeutics, Inc.较为活跃，换手率分别为796.08%、509.14%、188.44%，振幅较大的相关个股有Channel Therapeutics Corporation、Klotho Neurosciences Inc C/Wts 21/06/2029 、Dogwood Therapeutics, Inc.，振幅分别为96.32%、41.33%、38.48%。Immunome, Inc.公司简介：Immunome Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122014117960bda6e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122014117960bda6e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4563","IMNM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2504811523","title":"Immunome, Inc.盘中异动 股价大涨5.17%报10.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2504811523","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2504811523?lang=zh_cn&edition=full","pubTime":"2025-01-18 03:48","pubTimestamp":1737143333,"startTime":"0","endTime":"0","summary":"北京时间2025年01月18日03时48分，Immunome, Inc.股票出现异动，股价快速上涨5.17%。截至发稿，该股报10.37美元/股，成交量47.6734万股，换手率0.76%，振幅6.74%。Immunome, Inc.股票所在的生物技术行业中，整体涨幅为0.43%。其相关个股中，Channel Therapeutics Corporation、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大，Aditxt, Inc.、Channel Therapeutics Corporation、Phio Pharmaceuticals Corp.较为活跃，换手率分别为239.13%、81.29%、44.92%，振幅较大的相关个股有Channel Therapeutics Corporation、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Immatics N V C/Wts 01/07/2025 ，振幅分别为134.38%、53.37%、51.37%。Immunome, Inc.公司简介：Immunome Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501180348549607d84d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501180348549607d84d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMNM","BK4139","BK4563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503913375","title":"Immunome, Inc.盘中异动 早盘股价大涨5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503913375","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503913375?lang=zh_cn&edition=full","pubTime":"2025-01-16 22:31","pubTimestamp":1737037874,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日22时31分，Immunome, Inc.股票出现异动，股价急速上涨5.44%。截至发稿，该股报10.66美元/股，成交量5.8641万股，换手率0.09%，振幅0.74%。Immunome, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。其相关个股中，Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Aditxt, Inc.、Cytomed Therapeutics Limited涨幅较大，Aditxt, Inc.、Palisade Bio, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为941.56%、333.39%、192.52%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Aditxt, Inc.、Coeptis Therapeutics Holdings, Inc.，振幅分别为21.79%、11.22%、8.00%。Immunome, Inc.公司简介：Immunome Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116223114abad4ef7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116223114abad4ef7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMNM","BK4563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503515642","title":"Immunome, Inc.盘中异动 早盘快速拉升5.33%报9.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503515642","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503515642?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:30","pubTimestamp":1736951457,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时30分，Immunome, Inc.股票出现波动，股价大幅上涨5.33%。截至发稿，该股报9.88美元/股，成交量1.0104万股，换手率0.02%，振幅0.00%。Immunome, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Os Therapies Incorporated、Generation Bio Co.、Exicure, Inc.涨幅较大，Windtree Therapeutics, Inc.、Os Therapies Incorporated、Phio Pharmaceuticals Corp.较为活跃，换手率分别为183.27%、53.42%、49.93%，振幅较大的相关个股有Vincerx Pharma, Inc.、Onconetix, Inc.、Cibus, Inc.，振幅分别为10.72%、9.31%、7.58%。Immunome, Inc.公司简介：Immunome Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223057ababf1be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223057ababf1be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","IMNM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.immunome.com;investors.immunome.com","stockEarnings":[{"period":"1week","weight":-0.0284},{"period":"1month","weight":-0.1963},{"period":"3month","weight":0.2791},{"period":"6month","weight":0.1979},{"period":"1year","weight":1.4335},{"period":"ytd","weight":0.1159}],"compareEarnings":[{"period":"1week","weight":-0.0034},{"period":"1month","weight":-0.0096},{"period":"3month","weight":0.02},{"period":"6month","weight":0.1744},{"period":"1year","weight":0.1501},{"period":"ytd","weight":0.117}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Immunome, Inc.于2006年3月2日注册为宾夕法尼亚州公司，并于2015年12月2日转换为特拉华州公司。该公司是一家专注于靶向肿瘤疗法开发的生物技术公司。Immunome致力于构建多元化的差异化临床资产组合，以改善癌症患者的生活质量。其战略的核心在于抗体药物偶联物及其他肿瘤疗法的发现、设计、开发、生产和商业化方面的专业知识。Immunome正在推进包含多个临床和临床前资产的研发管线，这体现了其在肿瘤领域创新方面的承诺。","yearOnYearQuotes":[{"month":1,"riseRate":0.833333,"avgChangeRate":0.386574},{"month":2,"riseRate":0.333333,"avgChangeRate":0.253813},{"month":3,"riseRate":0.5,"avgChangeRate":-0.07544},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.111576},{"month":5,"riseRate":0.5,"avgChangeRate":-0.012173},{"month":6,"riseRate":0.333333,"avgChangeRate":0.000655},{"month":7,"riseRate":0.666667,"avgChangeRate":0.088644},{"month":8,"riseRate":0.333333,"avgChangeRate":0.056112},{"month":9,"riseRate":0.5,"avgChangeRate":0.145434},{"month":10,"riseRate":0.4,"avgChangeRate":0.031075},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.006249},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.09277}],"exchange":"NASDAQ","name":"Immunome Inc.","nameEN":"Immunome Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.0","shortVersion":"4.50.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Immunome Inc.(IMNM)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Immunome Inc.(IMNM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Immunome Inc.,IMNM,Immunome Inc.股票,Immunome Inc.股票老虎,Immunome Inc.股票老虎国际,Immunome Inc.行情,Immunome Inc.股票行情,Immunome Inc.股价,Immunome Inc.股市,Immunome Inc.股票价格,Immunome Inc.股票交易,Immunome Inc.股票购买,Immunome Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Immunome Inc.(IMNM)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Immunome Inc.(IMNM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}